Navigation Links
Genstar Capital Promotes J. Ryan Clark to Principal
Date:2/11/2008

SAN FRANCISCO, Feb. 11 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services, industrial technology, business services and software services, today announced that it has promoted J. Ryan Clark to Principal. Mr. Clark joined Genstar in 2004 and serves on the Boards of several Genstar portfolio companies, including Panolam Industries International, Inc., Fort Dearborn Company, PRA International, 21st Services, and Confie Seguros, the firm's most recent investment.

"Our people are the difference in our investments and as we continue to succeed in growing our portfolio of companies we are pleased to honor and recognize the achievements of our strong team of investment professionals," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Ryan has contributed greatly to a number of our key investments since he joined the firm and has been instrumental in building out our information and insurance services practice. All of us at Genstar congratulate him and look forward to working him for many years."

Prior to joining Genstar, Ryan was an Associate at Hellman & Friedman LLC, a private equity investment firm. Previously, he worked in the Mergers, Acquisitions and Restructuring Department at Morgan Stanley in New York. Ryan earned an MBA from the Harvard Business School, and an AB in Environmental Science and Public Policy from Harvard College.

Mr. Clark will continue to develop investment opportunities in the information and insurance services industries and has led the firm's investment in 21st Services, a Minneapolis-based company that provides life expectancy information used in the life settlement industry, and also Confie Seguros, a platform company to consolidate insurance brokerages primarily focused on the Hispanic consumer.

About Genstar Capital, LLC

Genstar Capital (http://www.gencap.com) is a leading private equity firm that for 20 years has been actively investing in high quality middle-market companies and building value in those businesses by utilizing the expertise of its operating partners. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating partners and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, industrial technology, software, and business services industries.

Contact: Chris Tofalli

Chris Tofalli Public Relations

914-834-4334


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genstar Capital Appoints Mark Hanson to Managing Director
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. AtriCure to Present at Roth Capital Partners 2007 New York Conference
4. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
5. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Advanced Life Sciences Joins NASDAQ Capital Market
10. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
11. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
Breaking Medicine Technology: